Tandem Diabetes Care (TNDM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -204,121 | -182,956 | -130,556 | -96,025 | -96,780 |
| Depreciation Amortization | 12,502 | 7,868 | 3,668 | 16,375 | 13,354 |
| Accounts receivable | -14,798 | -13,516 | -10,843 | -20,795 | -8,712 |
| Other Working Capital | 497 | 3,352 | -5,813 | -11,781 | 11,537 |
| Other Operating Activity | 186,410 | 157,478 | 125,266 | 136,451 | 94,109 |
| Operating Cash Flow | $-19,510 | $-27,774 | $-18,278 | $24,225 | $13,508 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 144,579 | 119,951 | 55,615 | 42,153 | -12,330 |
| PPE Investments | -13,263 | -9,171 | -2,965 | -19,231 | -16,162 |
| Net Acquisitions | -43,464 | -43,464 | -43,464 | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -46,404 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -46,404 | 0 |
| Investing Cash Flow | $87,852 | $67,316 | $9,186 | $-23,482 | $-28,492 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 306,850 | 306,850 |
| Debt Repayment | -40,760 | -40,760 | 0 | -261,936 | -261,936 |
| Common Stock Issued | -5,211 | -3,641 | -4,688 | -6,730 | -9,032 |
| Common Stock Repurchased | N/A | 0 | 0 | -30,000 | -30,000 |
| Other Financing Activity | 0 | 0 | 0 | 183 | 183 |
| Financing Cash Flow | $-45,971 | $-44,401 | $-4,688 | $8,367 | $6,065 |
| Exchange Rate Effect | 342 | -263 | -1,880 | 1,256 | -910 |
| Beginning Cash Position | 69,234 | 69,234 | 69,234 | 58,868 | 58,868 |
| End Cash Position | 91,947 | 64,112 | 53,574 | 69,234 | 49,039 |
| Net Cash Flow | $22,713 | $-5,122 | $-15,660 | $10,366 | $-9,829 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,510 | -27,774 | -18,278 | 24,225 | 13,508 |
| Capital Expenditure | -13,263 | -9,171 | -2,965 | -19,231 | -16,162 |
| Free Cash Flow | -32,773 | -36,945 | -21,243 | 4,994 | -2,654 |